Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

45.85

-1.60 (-3.37%)

Aug 21, 2026, 4:00 PM EDT - Market closed

Supernus Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	830.44	718.95	661.82	607.52	667.24	579.78
Revenue Growth	24.85%	8.63%	8.94%	-8.95%	15.09%	11.41%
Gross Profit	605.31	538.16	475.12	432.15	580.02	504.71
Operating Income	8.73	25.76	61.36	13.4	45.61	79.5
Net Income	-109.89	-38.55	73.87	1.32	60.71	53.42
Earnings Per Share	-1.91	-0.68	1.32	0.02	1.04	0.98
EPS Growth	-	-	6500.00%	-98.08%	6.32%	-58.48%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	372.07	308.67	453.61	271.49	555.23	458.85
Total Debt	40.17	40.98	34.27	41.53	450.76	440.25
Net Cash (Debt)	331.9	267.69	419.34	229.96	104.47	18.6
Net Cash Growth	-32.38%	-36.16%	82.35%	120.12%	461.74%	-94.47%
Net Cash Per Share	5.78	4.74	7.49	4.14	1.69	0.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	19.91	47.33	171.95	111.09	116.83	127.13
Capital Expenditures	-1.12	-1.34	-0.73	-0.55	-0.41	-2.05
Free Cash Flow	18.79	45.99	171.23	110.53	116.41	125.08
Free Cash Flow Growth	-89.89%	-73.14%	54.91%	-5.05%	-6.93%	-7.15%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	72.89%	74.85%	71.79%	71.13%	86.93%	87.05%
Operating Margin	1.05%	3.58%	9.27%	2.21%	6.84%	13.71%
Pretax Margin	-14.87%	-6.82%	14.79%	0.46%	9.10%	12.62%
Profit Margin	-13.23%	-5.36%	11.16%	0.22%	9.10%	9.21%
FCF Margin	2.26%	6.40%	25.87%	18.19%	17.45%	21.57%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	27.03	1201.42	31.76	29.03
Forward PE	13.05	19.33	19.65	15.34	30.84	15.73
P/FCF Ratio	141.86	61.96	11.66	14.30	16.56	12.40
PS Ratio	3.21	3.96	3.02	2.60	2.89	2.68